In addition, the co-existence of EGFR mutations and other genetic polymorphism that influence the prognosis of lung adenocarcinoma is not uncommon; the co-existence of EGFR mutation and endothelial nitric oxide synthase would significantly aggravate the lymph node invasion of lung adenocarcinoma [18]. This evidence concerns the gene NOS3 and lung adenocarcinoma.